Genzyme Exercises its Right to Purchase Additional Shares of Alnylam Common …

Genzyme Exercises its Right to Purchase Additional Shares of Alnylam Common …
Alnylam's genetic medicine programs are RNAi therapeutics directed toward genetically defined targets for the treatment of serious life-threatening diseases with limited treatment options for patients and their caregivers. … Actual results may differ …
Read more on PharmiWeb.com (press release)

The Fat Woman's Cancer?
Coplon's last radiation treatment was on September 5, 2013. … The Siteman Cancer Center and Washington University School of Medicine received a Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute. “We are …
Read more on Wicked Local Boxford

Let's not let stigma block way to effective treatment
Yet as Hillary Jacobs, director of the Massachusetts Bureau of Substance Abuse Services, appropriately said: “There are things besides [inpatient treatment] beds that are effective.” Methadone is a long-acting opiate medication that, when provided in a …
Read more on Boston Globe

SAGE Therapeutics Initiates Phase 1/2 Trial of SAGE-547 in Status Epilepticus
CAMBRIDGE, MA, USA I March 27, 2014 I SAGE Therapeutics, a biopharmaceutical company developing novel medicines to treat life-threatening and rare central nervous system (CNS) disorders, today announced dose initiation of the first patient in a Phase 1 …
Read more on PipelineReview.com (press release)

Drug Rehab Centers, Massachusetts, Help You Recover – Video — http://www.drugrehabvideo.com The benefits of drug rehab centers outside of the Massachusetts area give you a better chance at recovery. Drug addiction is ha…